Corvus Pharmaceuticals Inc buy Oppenheimer Holdings Inc.
Start price
20.03.24
/
50%
€1.67
Target price
20.03.25
€6.45
Performance (%)
-6.35%
Price
02.05.24
€1.44
Summary
This prediction is currently active. With a performance of -6.35%, the BUY prediction for Corvus Pharmaceuticals Inc by Oppenheimer_Holdings is down slightly. This prediction currently runs until 20.03.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Corvus Pharmaceuticals Inc | 8.912% | 8.912% |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $8.00 to $7.00. They now have an "outperform" rating on the stock.
Ratings data for CRVS provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.81
17.08.23
17.08.23
-
17.08.24
17.08.24
-20.33%
02.05.24
02.05.24